首页>
外国专利>
USE OF PIPAMPERONE AND A D2 RECEPTOR ANTAGONIST OR A SEROTONIN / DOPAMINE ANTAGONIST FOR THE TREATMENT OF PSYCHOTIC DISORDER
USE OF PIPAMPERONE AND A D2 RECEPTOR ANTAGONIST OR A SEROTONIN / DOPAMINE ANTAGONIST FOR THE TREATMENT OF PSYCHOTIC DISORDER
展开▼
机译:使用皮潘酮和D2受体拮抗剂或5-羟色胺/多巴胺拮抗剂治疗精神分裂症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the use of compounds and compositions of compounds having D4 and 5-HT2A antagonistic, partial agonistic or inverse agonistic activity for the treatment of the underlying dysregulation of the emotional functionality of mental disorders (i.e. affect instability - hypersensitivity - hyperaesthesia - dissociative phenomena - etc). The invention also relates to methods comprising administering to a patient diagnosed as having a neuropsychiatric disorder a pharmaceutical composition containing (i) compounds having D4 antagonistic, partial agonistic or inverse agonistic activity and (ii) compounds having 5-HT2A antagonistic, partial agonistic or inverse agonistic, and (iii) any known medicinal compound and compositions of said compounds. The combined D4 and 5-HT2A antagonistic, partial agonistic or inverse agonistic effects may reside within the same chemical or biological compound or in two different chemical and/or biological compounds.
展开▼